NavioMD Tirzepatide Review: Cost, a Verified Seal & Honest Verdict (2026)

NavioMD has a genuine LegitScript seal (#43281226) served directly from LegitScript's own CDN, alongside a real dual pathway — compounded tirzepatide plus brand-name Ozempic and Mounjaro. Every fact here comes from the company's own published program.

What NavioMD is

NavioMD is a telehealth platform, offering compounded tirzepatide alongside brand-name Ozempic and Mounjaro, plus women's HRT. LegitScript certified, with board-certified providers and US-licensed pharmacies, serving 48 states — all except Alabama and Mississippi.

What NavioMD costs

Compounded tirzepatide starts from $189/month at the entry dose, rising with tiered dosing ("as low as" pricing that climbs as your dose increases) up to $247/month at standard levels. Brand-name Ozempic runs $1,199/month and Mounjaro $1,249/month — you only pay for your current dose tier rather than a flat all-doses rate.

The brand-vs-compounded question

NavioMD offers both compounded tirzepatide and brand-name GLP-1 options (Ozempic, Mounjaro) — a real choice most compounded-only sellers don't give you, though the compounded option covers tirzepatide only, with no compounded semaglutide listed. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; the brand options are the exact molecules and doses that were. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

NavioMD's real strengths: a genuinely verified LegitScript seal, plus both compounded and brand-name options, 48-state coverage, extended hours (9am-10pm EST, seven days a week), and transparent tiered pricing where you only pay for your current dose. The trade-offs: not available in Alabama or Mississippi, the compounded option is tirzepatide only, it's a broader platform also offering women's HRT rather than a single-focus GLP-1 clinic, and entry prices climb as your dose increases rather than staying flat. As with any GLP-1 program, confirm your specific dose-tier price before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

NavioMD's genuinely verified LegitScript seal and real dual compounded-plus-brand pathway are strengths this review confirmed directly, and 48-state coverage is broad, but confirm your specific dose-tier price since it climbs as you titrate up rather than staying flat. For a provider with genuinely flat all-doses pricing, compare it against Mint Med or CoreAge Rx. See our best tirzepatide providers ranking for the full field.